Programme

08:00 Registration opens

09:00 Opening remarks

09:15 Present & Future of Drug-Device Combination: A strategic perspective
Didier Pertuy | former Vice President Global Head of Drug-Device Integrated Development & Device Strategy, SANOFI

09:45 Designing more precision into targeted delivery systems
Marianne Ashford | Senior principle scientist, Advanced Drug Delivery , Pharm Sci, AstraZeneca

10:15 Speed Networking

11:15 Change management and CMC best practices for streamlined injectable device development
Louise Place | GSK

11:45 Exhibitors highlights

12:30 Lunch Break, Exhibition and Posters

13:30 Introduction to the afternoon session

13:45 Discussion panel: Drug delivery of biologics and peptides – Direction of travel

14:45 Facilitating the administration of high-dose SC drugs: Will all IV drugs be transitioned to SC administration?
Philip Green | Chesapeake Pharma, formerly Executive Director, Biologic Device Strategy, Merck

15:15 Coffee break, Exhibition & Posters

16:00 Breathing New Life into Biologics: Challenges and Innovation in Inhaled and Nasal Biologics
Mireia Puig | Team Leader, Phillips Medisize

16:30 Polymer-based long acting injectables for delivery of peptides and large molecules
Patrick Duffy | Ashland

17:00 Concluding remarks

17:10 Conference ends